Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Improving diabetes-related family functioning and mutual family involvement with co-created family dialogue tools

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  2. Characteristics associated with non-disclosure of Type 2 diabetes at work

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Validation of suPAR turbidimetric assay on Cobas® (c502 and c702) and comparison to suPAR ELISA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Metformin monotherapy for adults with type 2 diabetes mellitus

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer
Aim:  To explore the putative association of new-onset diabetes and the soluble urokinase plasminogen activator receptor (suPAR), which is a new and stable plasma marker of immune function and low-grade inflammation. This association has been previously suggested by using the less sensitive International Classification of Disease system to detect incident diabetes in the Danish MONICA 10 cohort. Methods:  The Danish National Diabetes Register enabled more accurate identification of incident diabetes during a median follow-up of 13.8 years in the Danish MONICA 10 cohort (n = 2353 generally healthy individuals). The soluble urokinase plasminogen activator receptor was measured by the ELISA method. To fulfil model assumptions, outcome analyses were stratified by age, and further by smoking, owing to the interaction between the soluble urokinase plasminogen activator receptor and smoking on new-onset diabetes (P 
OriginalsprogEngelsk
TidsskriftDiabetic Medicine
Vol/bind29
Udgave nummer4
Sider (fra-til)479-487
ISSN0742-3071
DOI
StatusUdgivet - 2012

ID: 33087757